Abstract
Epidemiological data suggest that dietary factors may have a role in recent increases of the prevalence of allergic diseases. One food-related component might be the reduced consumption of ω3-polyunsaturated fatty acids observed especially in the Western societies; yet, clinical trials supplementing ω3-fatty acids to adults with established allergies and bronchial asthma have generally been disappointing. However, it is known that the immature immune system is highly susceptible to immuno-modulatory environmental conditions particularly in the pre- and postnatal period. This review discusses the immuno-modulatory effects of ω3-fatty acids supplementation in the perinatal life phase on the immune system of the child. Evidence exists that perinatal ω3-fatty acid exposure affects T-cells and antigen presenting cells of the neonates likely due to altered eicosanoid metabolism. Although animal experiments strongly suggest a role of maternal ω3-fatty acid intake on allergic immune responses in the offspring, the beneficial effect of ω3-fatty acid supplementation has been studied in a small number of clinical trials. In these studies perinatal supplementation had some positive effects on distinct clinical phenotypes of the atopic syndrome. However, more studies are needed to fully explore the opportunity of perinatal immuno-modulation.
References
[1] Beck M, G Zelczak, MJ Lentze: Abnormal fatty acid composition in umbilical cord blood of infants at high risk of atopic disease. Acta Paediatr89 (2000) 279Search in Google Scholar
[2] Black PN, S Sharpe: Dietary fat and asthma: is there a connection? Eur Respir J10 (1997) 6Search in Google Scholar
[3] Boris J, B Jensen, JD Salvig, NJ Secher, SF Olsen: A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n-3 fatty acid content in human breast milk. Lipids39 (2004) 1191Search in Google Scholar
[4] Calder PC: Fatty acids, dietary lipids and lymphocyte functions. Biochem Soc Trans23 (1995) 302Search in Google Scholar
[5] Calder PC, P Yaqoob, F Thies, FA Wallace, EA Miles: Fatty acids and lymphocyte functions. Br J Nutr87 (2002) S3110.1079/BJN2001455Search in Google Scholar PubMed
[6] Denburg JA, HM Hatfield, MM Cyr, L Hayes, PG Holt, R Sehmi, et al.: Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatr Res57 (2005) 276Search in Google Scholar
[7] De Vriese SR, C Matthys, S De Henauw, G De Backer, M Dhont, AB Christophe: Maternal and umbilical fatty acid status in relation to maternal diet. Prostaglandins Leukot Essent Fatty Acids67 (2002) 389Search in Google Scholar
[8] Duchen K, G Yu, B Bjorksten: Polyunsaturated fatty acids in breast milk in relation to atopy in the mother and her child. Int Arch Allergy Immunol118 (1999) 321Search in Google Scholar
[9] Dunstan JA, TA Mori, A Barden, LJ Beilin, AL Taylor, PG Holt, et al.: Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. J Allergy Clin Immunol112 (2003) 1178Search in Google Scholar
[10] Dunstan JA, TA Mori, A Barden, LJ Beilin, AL Taylor, PG Holt, et al.: Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy. Clin Exp Allergy33 (2003) 442Search in Google Scholar
[11] Dunstan JA, TA Mori, A Barden, LJ Beilin, PG Holt, PC Calder, et al.: Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. Eur J Clin Nutr58 (2004) 429Search in Google Scholar
[12] Dunstan JA, J Roper, L Mitoulas, PE Hartmann, K Simmer, SL Prescott: The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clin Exp Allergy34 (2004) 1237Search in Google Scholar
[13] Dutta-Roy AK: Cellular uptake of long-chain fatty acids: role of membrane-associated fatty-acid-binding/transport proteins. Cell Mol Life Sci57 (2000) 136010.1007/PL00000621Search in Google Scholar PubMed
[14] Friedman Z, A Danon, EL Lamberth Jr, WJ Mann: Cord blood fatty acid composition in infants and in their mothers during the third trimester. J Pediatr92 (1978) 461Search in Google Scholar
[15] Galli E, M Picardo, L Chini, S Passi, V Moschese, O Terminali, et al.: Analysis of polyunsaturated fatty acids in newborn sera: a screening tool for atopic disease? Br J Dermatol130 (1994) 752Search in Google Scholar
[16] Gold DR, BM Willwerth, KG Tantisira, PW Finn, B Schaub, DL Perkins, et al.: Associations of cord blood fatty acids with lymphocyte proliferation, IL-13, and IFN-gamma. J Allergy Clin Immunol117 (2006) 931Search in Google Scholar
[17] Hawkes JS, DL Bryan, MA Neumann, M Makrides, RA Gibson: Transforming growth factor beta in human milk does not change in response to modest intakes of docosahexaenoic acid. Lipids36 (2001) 1179Search in Google Scholar
[18] Herrera E: Implications of dietary fatty acids during pregnancy on placental, fetal and postnatal development – a review. Placenta23 (2002) S910.1053/plac.2002.0771Search in Google Scholar PubMed
[19] Innis SM: Polyunsaturated fatty acids in human milk: an essential role in infant development. Adv Exp Med Biol554 (2004) 2710.1007/978-1-4757-4242-8_5Search in Google Scholar PubMed
[20] Jarvinen KM, ST Laine, AL Jarvenpaa, HK Suomalainen: Does low IgA in human milk predispose the infant to development of cow's milk allergy? Pediatr Res48 (2000) 457Search in Google Scholar
[21] Jones CA, JA Holloway, EJ Popplewell, ND Diaper, JW Holloway, GH Vance, et al.: Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or both. J Allergy Clin Immunol109 (2002) 858Search in Google Scholar
[22] Khair-el-Din TA, SC Sicher, MA Vazquez, WJ Wright, CY Lu: Docosahexaenoic acid, a major constituent of fetal serum and fish oil diets, inhibits IFN gamma-induced Ia-expression by murine macrophages in vitro. J Immunol154 (1995) 1296Search in Google Scholar
[23] Korotkova M, B Gabrielsson, LA Hanson, B Strandvik: Maternal essential fatty acid deficiency depresses serum leptin levels in suckling rat pups. J Lipid Res42 (2001) 359Search in Google Scholar
[24] Korotkova M, E Telemo, LA Hanson, B Strandvik: Modulation of neonatal immunological tolerance to ovalbumin by maternal essential fatty acid intake. Pediatr Allergy Immunol15 (2004) 112Search in Google Scholar
[25] Korotkova M, E Telemo, Y Yamashiro, LA Hanson, B Strandvik: The ratio of n-6 to n-3 fatty acids in maternal diet influences the induction of neonatal immunological tolerance to ovalbumin. Clin Exp Immunol137 (2004) 237Search in Google Scholar
[26] Lauritzen L, MH Jorgensen, HS Hansen, KF Michaelsen: Fluctuations in human milk long-chain PUFA levels in relation to dietary fish intake. Lipids37 (2002) 237Search in Google Scholar
[27] Lee TH, RL Hoover, JD Williams, RI Sperling, J Ravalese III, BW Spur, et al.: Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med312 (1985) 1217Search in Google Scholar
[28] Lee JY, KH Sohn, SH Rhee, D Hwang: Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem276 (2001) 16683Search in Google Scholar
[29] Lee JY, A Plakidas, WH Lee, A Heikkinen, P Chanmugam, G Bray, et al.: Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res44 (2003) 479Search in Google Scholar
[30] Lord GM, G Matarese, JK Howard, RJ Baker, SR Bloom, RI Lechler: Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature394 (1998) 897Search in Google Scholar
[31] Makrides M, MA Neumann, RA Gibson: Effect of maternal docosahexaenoic acid (DHA) supplementation on breast milk composition. Eur J Clin Nutr50 (1996) 352Search in Google Scholar
[32] Mihrshahi S, JK Peat, K Webb, W Oddy, GB Marks, CM Mellis: Effect of omega-3 fatty acid concentrations in plasma on symptoms of asthma at 18 months of age. Pediatr Allergy Immunol15 (2004) 517Search in Google Scholar
[33] Nafstad P, W Nystad, P Magnus, JJ Jaakkola: Asthma and allergic rhinitis at 4 years of age in relation to fish consumption in infancy. J Asthma40 (2003) 343Search in Google Scholar
[34] Otto SJ, AC van Houwelingen, G Hornstra: The effect of supplementation with docosahexaenoic and arachidonic acid derived from single cell oils on plasma and erythrocyte fatty acids of pregnant women in the second trimester. Prostaglandins Leukot Essent Fatty Acids63 (2000) 323Search in Google Scholar
[35] Peat JK, S Mihrshahi, AS Kemp, GB Marks, ER Tovey, K Webb, et al.: Three-year outcomes of dietary fatty acid modification and house dust mite reduction in the Childhood Asthma Prevention Study. J Allergy Clin Immunol114 (2004) 807Search in Google Scholar
[36] Rinas U, G Horneff, V Wahn: Interferon-gamma production by cord-blood mononuclear cells is reduced in newborns with a family history of atopic disease and is independent from cord blood IgE-levels. Pediatr Allergy Immunol4 (1993) 60Search in Google Scholar
[37] Sorensen JD, SF Olsen, AK Pedersen, J Boris, NJ Secher, GA FitzGerald: Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. Am J Obstet Gynecol168 (1993) 915Search in Google Scholar
[38] Stene LC, J Ulriksen, P Magnus, G Joner: Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia43 (2000) 1093Search in Google Scholar
[39] Stene LC, G Joner: Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am J Clin Nutr78 (2003) 1128Search in Google Scholar
[40] Stoney RM, RK Woods, CS Hosking, DJ Hill, MJ Abramson, FC Thien: Maternal breast milk long-chain n-3 fatty acids are associated with increased risk of atopy in breastfed infants. Clin Exp Allergy34 (2004) 194Search in Google Scholar
[41] Strachan DP: Hay fever, hygiene, and household size. Br Med J299 (1989) 1259Search in Google Scholar
[42] Stulnig TM: Immunomodulation by polyunsaturated fatty acids: mechanisms and effects. Int Arch Allergy Immunol132 (2003) 31010.1159/000074898Search in Google Scholar PubMed
[43] Tang ML, AS Kemp, J Thorburn, DJ Hill: Reduced interferon-gamma secretion in neonates and subsequent atopy. Lancet344 (1994) 983Search in Google Scholar
[44] Upham JW, LM Hayes, J Lundahl, R Sehmi, JA Denburg: Reduced expression of hemopoietic cytokine receptors on cord blood progenitor cells in neonates at risk for atopy. J Allergy Clin Immunol104 (1999) 370Search in Google Scholar
[45] Vidal K, MO Labeta, EJ Schiffrin, A Donnet-Hughes: Soluble CD14 in human breast milk and its role in innate immune responses. Acta Odontol Scand59 (2001) 330Search in Google Scholar
[46] Williams TJ, CA Jones, EA Miles, JO Warner, JA Warner: Fetal and neonatal IL-13 production during pregnancy and at birth and subsequent development of atopic symptoms. J Allergy Clin Immunol105 (2000) 951Search in Google Scholar
[47] Woods RK, FC Thien, MJ Abramson: Dietary marine fatty acids (fish oil) for asthma in adults and children. Cochrane Database Syst Rev (2002) CD001283Search in Google Scholar
[48] Yu G, NI Kjellman, B Bjorksten: Phospholipid fatty acids in cord blood: family history and development of allergy. Acta Paediatr85 (1996) 679Search in Google Scholar
[49] Yu G, B Bjorksten: Serum levels of phospholipid fatty acids in mothers and their babies in relation to allergic disease. Eur J Pediatr157 (1998) 298Search in Google Scholar
©2007 by Walter de Gruyter Berlin New York
